Search

  • HOME
  • Search
Case Reports
Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
Ye Jin Ahn, Hyung Bin Hwang, Sung Kun Chung
Korean J Ophthalmol. 2014;28(2):177-180.   Published online March 14, 2014
Full textFull text    PubreaderPubReader    PDFPDF    
Original Articles
Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography
Joo Young Shin, Se Joon Woo, Jeeyun Ahn, Kyu Hyung Park
Korean J Ophthalmol. 2013;27(6):425-432.   Published online November 15, 2013
Full textFull text    PubreaderPubReader    PDFPDF    
The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
Jin-Hyoung Kim, Hae-Won Seo, Hyun-Cheol Han, Jong-Hyun Lee, Suk-Kyue Choi, Doh Lee
Korean J Ophthalmol. 2013;27(4):235-242.   Published online July 5, 2013
Full textFull text    PubreaderPubReader    PDFPDF    
Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy
Han Joo Cho, Ji Seon Baek, Dong Won Lee, Chul Gu Kim, Jong Woo Kim
Korean J Ophthalmol. 2012;26(3):157-162.   Published online May 22, 2012
Full textFull text    PubreaderPubReader    PDFPDF    

Korean Journal of
Ophthalmology

Print ISSN: 1011-8942
Online ISSN: 2092-9382



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6788    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2025 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next